Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 2 blogs

twitter: 6 tweeters

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Blogs Twitter Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany

Article in Pulmonary Pharmacology & Therapeutics (March 2023)

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection

Article in Antibiotics (March 2023)